Daito Pharmaceutical Co Ltd
TSE:4577
Daito Pharmaceutical Co Ltd
TSE:4577
Price:
2 224
JPY
1.78%
Market Cap:
34.1B
JPY
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
5.3
Current
4.2
Median
12.7
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=5.3
Enterprise Value
/
38.2B JPY
EBITDA
7.1B JPY
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
5.1
2-Years Forward
EV/EBITDA
4.2
3-Years Forward
EV/EBITDA
3.8
You don't have any saved screeners yet
